{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:35:16Z","timestamp":1793435716524,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,9]],"date-time":"2027-10-09T00:00:00Z","timestamp":1823040000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH125181"],"award-info":[{"award-number":["MH125181"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cct.2026.108498","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:50Z","timestamp":1791475370000},"page":"108498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Randomized controlled trial of acute ketamine versus midazolam for recurrence of suicidality in adolescents (TASK): Rationale, design, and baseline characteristics"],"prefix":"10.1016","volume":"170","author":[{"given":"Madhukar H.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherise R.","family":"Chin Fatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Rabia","family":"Ayvaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn L.","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rebstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Spain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deryk","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kimatian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Monastirsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Minhajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy D.","family":"Kennard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J.","family":"Emslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2026.108498_bb0005","author":"Centers for Disease Control and Prevention, Suicide Prevention"},{"key":"10.1016\/j.cct.2026.108498_bb0010","series-title":"Web-Based Injury Statistics Query and Reporting System (WISQARS)","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"3","key":"10.1016\/j.cct.2026.108498_bb0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jadohealth.2018.09.015","article-title":"The development and feasibility outcomes of a youth suicide prevention intensive outpatient program","volume":"64","author":"Kennard","year":"2019","journal-title":"J. Adolesc. Health"},{"issue":"10","key":"10.1016\/j.cct.2026.108498_bb0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/CHI.0b013e3181b5dbe4","article-title":"The treatment of adolescent suicide attempters study (TASA): predictors of suicidal events in an open treatment trial","volume":"48","author":"Brent","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.cct.2026.108498_bb0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/JPR.S131156","article-title":"Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study","volume":"10","author":"Sheehy","year":"2017","journal-title":"J. Pain Res."},{"issue":"9","key":"10.1016\/j.cct.2026.108498_bb0030","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of Esketamine nasal spray plus Oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.cct.2026.108498_bb0035","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41380-018-0311-2","article-title":"Correction: double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.cct.2026.108498_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and Esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2026.108498_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067194","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"Bmj"},{"key":"10.1016\/j.cct.2026.108498_bb0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/NDT.S401032","article-title":"Acute effects of intravenous sub-anesthetic doses of ketamine and intranasal inhaled Esketamine on suicidal ideation: a systematic review and meta-analysis","volume":"19","author":"hen","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.cct.2026.108498_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231151327","article-title":"Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review","volume":"13","author":"Jollant","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.cct.2026.108498_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2026.108498_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress. Anxiety"},{"issue":"7","key":"10.1016\/j.cct.2026.108498_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/cap.2018.0030","article-title":"Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study","volume":"28","author":"Cullen","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.cct.2026.108498_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaac.2017.01.006","article-title":"Ketamine as a treatment for adolescent depression: a case report","volume":"56","author":"Dwyer","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2026.108498_bb0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2020.20010018","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial","volume":"178","author":"Dwyer","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.cct.2026.108498_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaac.2023.05.031","article-title":"Effect of repeated intravenous Esketamine on adolescents with major depressive disorder and suicidal ideation: a randomized active-placebo-controlled trial","volume":"63","author":"Zhou","year":"2024","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"7","key":"10.1016\/j.cct.2026.108498_bb0090","article-title":"A systematic review on ketamine and Esketamine for treatment-resistant depression and suicidality in adolescents: a new Hope?","volume":"11","author":"Pardossi","year":"2024","journal-title":"Children (Basel)"},{"key":"10.1016\/j.cct.2026.108498_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2024.107777","article-title":"Ketamine treatment in youth for fast reduction of suicidality and engagement in psychotherapy: a randomized placebo-controlled trial protocol","volume":"149","author":"Reilly-Harrington","year":"2025","journal-title":"Contemp. Clin. Trials"},{"issue":"Suppl. 20","key":"10.1016\/j.cct.2026.108498_bb0100","first-page":"22","article-title":"The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.cct.2026.108498_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","article-title":"Reliability and validity of the Mini international neuropsychiatric interview for children and adolescents (MINI-KID)","volume":"71","author":"Sheehan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.cct.2026.108498_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","article-title":"Mini international neuropsychiatric interview for children and adolescents (MINI-KID)","volume":"71","author":"Sheehan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2026.108498_bb0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/cap.2015.0112","article-title":"Prevalence and treatment outcomes of persistent negative mood among children with attention-deficit\/hyperactivity disorder and aggressive behavior","volume":"26","author":"Blader","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.cct.2026.108498_bb0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","article-title":"The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research","volume":"49","author":"Sangha","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cct.2026.108498_bb0125","series-title":"Traumatic Events Screening Inventory for Children (TESI-C) Version 8.4","author":"Ford","year":"2002"},{"issue":"7","key":"10.1016\/j.cct.2026.108498_bb0130","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.cct.2026.108498_bb0135","series-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","first-page":"41","article-title":"Timeline follow-Back","author":"Sobell","year":"1992"},{"issue":"6","key":"10.1016\/j.cct.2026.108498_bb0140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4088\/JCP.11m06837","article-title":"Concise health risk tracking scale: a brief self-report and clinician rating of suicidal risk","volume":"72","author":"Trivedi","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.cct.2026.108498_bb0145","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1469-7610.2012.02561.x","article-title":"The affective reactivity index: a concise irritability scale for clinical and research settings","volume":"53","author":"Stringaris","year":"2012","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"10","key":"10.1016\/j.cct.2026.108498_bb0150","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0006-3223(96)00548-3","article-title":"The Altman self-rating mania scale","volume":"42","author":"Altman","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2026.108498_bb0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1037\/pas0000640","article-title":"Borderline personality features scale for Children-11: measurement invariance over time and across gender in a community sample of adolescents","volume":"31","author":"Vanwoerden","year":"2019","journal-title":"Psychol. Assess."},{"issue":"5","key":"10.1016\/j.cct.2026.108498_bb0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1176\/appi.ajp.2018.18030355","article-title":"Irritability and its clinical utility in major depressive disorder: prediction of individual-level acute-phase outcomes using early changes in irritability and depression severity","volume":"176","author":"Jha","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2026.108498_bb0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ijnp\/pyx097","article-title":"Worsening anxiety, irritability, insomnia, or panic predicts poorer antidepressant treatment outcomes: clinical utility and validation of the concise associated symptom tracking (CAST) scale","volume":"21","author":"Jha","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.cct.2026.108498_bb0170","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jpsychires.2009.01.013","article-title":"Demographic and childhood environmental predictors of resilience in a community sample","volume":"43","author":"Campbell-Sills","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.cct.2026.108498_bb0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jts.20271","article-title":"Psychometric analysis and refinement of the Connor-davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience","volume":"20","author":"Campbell-Sills","year":"2007","journal-title":"J. Trauma. Stress."},{"issue":"2","key":"10.1016\/j.cct.2026.108498_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","volume":"44","author":"Rosenbaum","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2026.108498_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4603(94)00058-1","article-title":"Norms and sensitivity of the adolescent version of the drug use screening inventory","volume":"20","author":"Kirisci","year":"1995","journal-title":"Addict. Behav."},{"issue":"10","key":"10.1016\/j.cct.2026.108498_bb0190","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.cct.2026.108498_bb0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40264-017-0633-z","article-title":"A review of methods for monitoring adverse events in pediatric psychopharmacology clinical trials","volume":"41","author":"Coates","year":"2018","journal-title":"Drug Saf."},{"issue":"12","key":"10.1016\/j.cct.2026.108498_bb0200","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/01.chi.0000142668.29191.13","article-title":"Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology","volume":"43","author":"Greenhill","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.cct.2026.108498_bb0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2147\/NDT.S406909","article-title":"Psychometrics of the concise health risk tracking self-report (CHRT-SR16) assessment of suicidality in a sample of adults with moderate to severe methamphetamine use disorder: findings from the ADAPT-2 randomized trial","author":"Trombello","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.cct.2026.108498_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mpr.321","article-title":"Psychometric properties of the quick inventory of depressive symptomatology in adolescents","volume":"19","author":"Bernstein","year":"2010","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.cct.2026.108498_bb0215","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4088\/JCP.v68n0917","article-title":"A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology","volume":"68","author":"Moore","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2026.108498_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaac.2015.10.008","article-title":"Using implicit and explicit measures to predict nonsuicidal self-injury among adolescent inpatients","volume":"55","author":"Cha","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2026.108498_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1037\/a0015575","article-title":"Understanding and using the implicit association test: III. Meta-analysis of predictive validity","volume":"97","author":"Greenwald","year":"2009","journal-title":"J. Pers. Soc. Psychol."},{"issue":"3","key":"10.1016\/j.cct.2026.108498_bb0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/appi.ajp.2019.18080911","article-title":"An electroencephalography connectomic profile of posttraumatic stress disorder","volume":"177","author":"Toll","year":"2020","journal-title":"Am. J. Psychiatry"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:17:57Z","timestamp":1793434677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426002843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S1551714426002843"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108498","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled trial of acute ketamine versus midazolam for recurrence of suicidality in adolescents (TASK): Rationale, design, and baseline characteristics","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108498"}}